Management of Secondary Glaucoma in Tertiary Care Centre in Western Odisha
Authors/Creators
- 1. Associate Professor & HOD, Department of Ophthalmology, VSSIMSAR, Burla, Odisha, India
- 2. Assistant Professor, Department of Ophthalmology, VSSIMSAR, Burla, Odisha, India
- 3. Senior Resident, Department of Ophthalmology, VSSIMSAR, Burla, Odisha, India
- 4. Associate Professor, Department of Ophthalmology, VSSIMSAR, Burla, Odisha, India
Description
Background: Glaucoma’s characterized by secondary angle closure differ from glaucomas characterised by primary angle closure (PACG). In contrast to primary angle closure glaucoma, secondary angle closure glaucoma is characterised by identifiable contributory factors for angle closure and obstruction of aqueous flow, which are typically unaffected by iridotomy. Each type of secondary angle closure glaucoma is managed differently; therefore, diagnosing the underlying cause is essential for its effective treatment. This study’s objective was to assess the significance of these management plans. Methods: This investigation was conducted between March 2021 and April 2023 at the Department of Ophthalmology, VSSIMSAR, Burla, Sambalpur, Odisha. All patients who visited the glaucoma clinic were enrolled in this investigation, their glaucoma was classified, and the appropriate treatment was initiated to achieve the 15 mmHg target pressure. Findings: 212 patients were examined in total. The number of male patients was greater than that of female patients by 66.04 percent. Among secondary glaucomas, inflammatory glaucomas were the most prevalent, constituting 28.30% of all cases. The age cohort between 51 and 60 years represented 28.30% of all primary glaucoma cases. Oral and intravenous hyperosmotic drugs were administered, along with topical B blockers, miotics, sympathomimetic, prostaglandin analogues, hyperosmotic drugs and steroids. Trabeculectomy was the most prevalent surgical option for controlling intraocular pressure. Yag laser iridotomies were also performed when necessary. Control of intraocular pressure and visual outcome is quite satisfactory following treatment. Conclusion: The most prevalent cause of secondary glaucoma is inflammatory glaucoma. They could be effectively managed if they were timely. In addition to steroids, medical antiglaucoma therapy serves an important role in the treatment of glaucoma. Trabeculectomy is highly efficacious in cases of resistance.
Abstract (English)
Background: Glaucoma’s characterized by secondary angle closure differ from glaucomas characterised by primary angle closure (PACG). In contrast to primary angle closure glaucoma, secondary angle closure glaucoma is characterised by identifiable contributory factors for angle closure and obstruction of aqueous flow, which are typically unaffected by iridotomy. Each type of secondary angle closure glaucoma is managed differently; therefore, diagnosing the underlying cause is essential for its effective treatment. This study’s objective was to assess the significance of these management plans. Methods: This investigation was conducted between March 2021 and April 2023 at the Department of Ophthalmology, VSSIMSAR, Burla, Sambalpur, Odisha. All patients who visited the glaucoma clinic were enrolled in this investigation, their glaucoma was classified, and the appropriate treatment was initiated to achieve the 15 mmHg target pressure. Findings: 212 patients were examined in total. The number of male patients was greater than that of female patients by 66.04 percent. Among secondary glaucomas, inflammatory glaucomas were the most prevalent, constituting 28.30% of all cases. The age cohort between 51 and 60 years represented 28.30% of all primary glaucoma cases. Oral and intravenous hyperosmotic drugs were administered, along with topical B blockers, miotics, sympathomimetic, prostaglandin analogues, hyperosmotic drugs and steroids. Trabeculectomy was the most prevalent surgical option for controlling intraocular pressure. Yag laser iridotomies were also performed when necessary. Control of intraocular pressure and visual outcome is quite satisfactory following treatment. Conclusion: The most prevalent cause of secondary glaucoma is inflammatory glaucoma. They could be effectively managed if they were timely. In addition to steroids, medical antiglaucoma therapy serves an important role in the treatment of glaucoma. Trabeculectomy is highly efficacious in cases of resistance.
Files
IJPCR,Vol15,Issue8,Article164.pdf
Files
(327.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5fe01dfc0ab3f000805ebc3176dc27f6
|
327.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-08-15
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue8,Article164.pdf
- Development Status
- Active
References
- 1. Das J, Bhomaj S, Chaudhuri Z, et al. Profile of glaucoma in a major eye hospital in North India. Indian J Ophthalmol. 2001; 49(1):25-30. 2. Khan MD, Quraish ND, Khan MA. Facts about status of blindness in Pakistan Pak J Ophthalmol. 1999; 15: 15-9. 3. Krishnadas R, Ramakrishnan R. Secondary Glaucomas. The Tasks ahead. Community eye health. 2001; 14: 40-2. 4. Pozzi SAP, Wahieg R, Roasen B, et al. Secondary glaucoma in Paraguay. Etiology and medicine Ophthalmology. 1999; 96: 359- 63. 5. Jafers BL, et al. World Health Organization PBC/94.40 Global data on Blindness an update. 6. Anthony JH. Secondary glaucoma clinical and Experimental Optometry. 2000; 83: 190-4. 7. Baber FT, Saeed N, ZubairM, et al. Two year audit of glaucoma admitted patients in Hayatabad Medical Complex Peshawar. Pak J Ophthalmol. 2003: 19: 32-40. 8. Quigley HA. The number of people with glaucoma worldwide. Br J Ophthalmol. 1996; 80: 389-93. 9. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: The Aravind comprehensive eye survey. Ophthalmology. 2003; 110(8):1484-1490. 10. Das J, Bhomaj S, Chaudhuri Z, et al. Profile of glaucoma in a major eye hospital in North India. Indian J Ophthalmol. 2001;49(1):25-30. 11. Gadia R, Sihota R, Dada T, et al. Current profile of secondary glaucomas. Indian J Ophthalmol. 2008; 56(4):285-289. 12. Qureshi MB, Khan MD, Shah MN, et al. Glaucoma admissions and surgery in public sector tertiary care hospitals in Pakistan: results of a National study. Ophthalmic Epidemiolol. 2006; 13(2):115-119. 13. Teikari JM, O'Donnell J. Epidemiologic data on adult glaucomas: data from the hospital discharge registry and the registry of right to free medication. Acta Ophthalmol (Copenh). 1989; 67(2):184-191. 14. Yamamoto T, Iwase A, Araie M, et al. The Tajimi Study report 2-prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005; 112(10):1661-1669. 15. Shaikh A, Alam P, Sami MS. Tobacco related eye diseases. Pak J Ophthalmol. 1999; 15: 113- 6. 16. Agarwal HC, Sood NN, Kalra BR, et al. Secondary glaucoma. Indian J Ophthalmol. 1982; 30: 121-4. 17. Lloves MJ, Power JW, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999; 213: 300-4. 18. Donal L, Bundez MD, Katia E, et al. Surgical Management of secondary glaucoma after pars plana vitrectomy and silicon oil injection for complex retinal detachment. Ophthalmology. 2001; 108; 1028-32.